Cargando…
Structural basis for blocking PD-1-mediated immune suppression by therapeutic antibody pembrolizumab
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223238/ https://www.ncbi.nlm.nih.gov/pubmed/27325296 http://dx.doi.org/10.1038/cr.2016.77 |
| _version_ | 1782493136422961152 |
|---|---|
| author | Na, Zhenkun Yeo, Siok Ping Bharath, Sakshibeedu R Bowler, Matthew W Balıkçı, Esra Wang, Cheng-I Song, Haiwei |
| author_facet | Na, Zhenkun Yeo, Siok Ping Bharath, Sakshibeedu R Bowler, Matthew W Balıkçı, Esra Wang, Cheng-I Song, Haiwei |
| author_sort | Na, Zhenkun |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5223238 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-52232382017-01-12 Structural basis for blocking PD-1-mediated immune suppression by therapeutic antibody pembrolizumab Na, Zhenkun Yeo, Siok Ping Bharath, Sakshibeedu R Bowler, Matthew W Balıkçı, Esra Wang, Cheng-I Song, Haiwei Cell Res Letter to the Editor Nature Publishing Group 2017-01 2016-06-21 /pmc/articles/PMC5223238/ /pubmed/27325296 http://dx.doi.org/10.1038/cr.2016.77 Text en Copyright © 2017 Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences http://creativecommons.org/licenses/by-nc-sa/4.0/ This license allows readers to copy, distribute and transmit the Contribution as long as it attributed back to the author. Readers are permitted to alter, transform or build upon the Contribution as long as the resulting work is then distributed under this is a similar license. Readers are not permitted to use the Contribution for commercial purposes. Please read the full license for further details at - http://creativecommons.org/licenses/by-nc-sa/4.0/ |
| spellingShingle | Letter to the Editor Na, Zhenkun Yeo, Siok Ping Bharath, Sakshibeedu R Bowler, Matthew W Balıkçı, Esra Wang, Cheng-I Song, Haiwei Structural basis for blocking PD-1-mediated immune suppression by therapeutic antibody pembrolizumab |
| title | Structural basis for blocking PD-1-mediated immune suppression by therapeutic antibody pembrolizumab |
| title_full | Structural basis for blocking PD-1-mediated immune suppression by therapeutic antibody pembrolizumab |
| title_fullStr | Structural basis for blocking PD-1-mediated immune suppression by therapeutic antibody pembrolizumab |
| title_full_unstemmed | Structural basis for blocking PD-1-mediated immune suppression by therapeutic antibody pembrolizumab |
| title_short | Structural basis for blocking PD-1-mediated immune suppression by therapeutic antibody pembrolizumab |
| title_sort | structural basis for blocking pd-1-mediated immune suppression by therapeutic antibody pembrolizumab |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223238/ https://www.ncbi.nlm.nih.gov/pubmed/27325296 http://dx.doi.org/10.1038/cr.2016.77 |
| work_keys_str_mv | AT nazhenkun structuralbasisforblockingpd1mediatedimmunesuppressionbytherapeuticantibodypembrolizumab AT yeosiokping structuralbasisforblockingpd1mediatedimmunesuppressionbytherapeuticantibodypembrolizumab AT bharathsakshibeedur structuralbasisforblockingpd1mediatedimmunesuppressionbytherapeuticantibodypembrolizumab AT bowlermattheww structuralbasisforblockingpd1mediatedimmunesuppressionbytherapeuticantibodypembrolizumab AT balıkcıesra structuralbasisforblockingpd1mediatedimmunesuppressionbytherapeuticantibodypembrolizumab AT wangchengi structuralbasisforblockingpd1mediatedimmunesuppressionbytherapeuticantibodypembrolizumab AT songhaiwei structuralbasisforblockingpd1mediatedimmunesuppressionbytherapeuticantibodypembrolizumab |